柔性乙状结肠镜筛查在不同性别和年龄组中的效果:随机试验汇总分析
该汇总分析纳入三项随机对照试验共287 928人,比较柔性乙状结肠镜筛查对结直肠癌发病和死亡的效果。结果显示筛查对男性和女性均降低结直肠癌发病率,但女性60岁及以上获益不显著,且近端结肠无效果。提示对60岁以上女性应考虑能更有效检测近端肿瘤的替代筛查方法。
要点
- 柔性乙状结肠镜筛查降低男性结直肠癌发病率(RR 0.76)。
- 女性总体发病风险降低(RR 0.83),但60岁及以上不显著。
- 60岁以上女性近端结肠筛查无效果,性别与年龄组交互显著。
核心结论
- 柔性乙状结肠镜对男性和年轻女性是有效的结直肠癌筛查工具。
- 60岁以上女性获益较小且无统计学意义,应考虑替代筛查方法。
研究设计与样本
- 汇总分析美国PLCO、意大利SCORE和挪威NORCCAP三项随机试验的聚合数据。
- 共纳入287 928人,筛查组115 139人,常规照护组172 789人。
- 纳入年龄分别为55-74岁(PLCO)、55-64岁(SCORE)和50-64岁(NORCCAP)。
- 筛查组接受一次(SCORE和NORCCAP)或两次(PLCO)柔性乙状结肠镜筛查,对照组接受常规照护。
- 中位随访时间为10.5至12.1年。
主要发现
- 筛查降低男性结直肠癌发病率(相对风险0.76;95%CI 0.70至0.83)。
- 筛查降低女性结直肠癌发病率(相对风险0.83;95%CI 0.75至0.92)。
- 男性60岁以下与60岁以上筛查效果无差异。
- 女性60岁以下结直肠癌发病率降低(相对风险0.71;95%CI 0.59至0.84),60岁及以上不显著(0.90;95%CI 0.80至1.02)。
- 男性和60岁以下女性结直肠癌死亡率显著降低;远端结肠发病率降低程度相似,但60岁以上女性近端结肠无效果(性别与年龄组交互P=0.04)。
关键数值与推荐
- 筛查依从率:SCORE为58%,NORCCAP为63%,PLCO为87%。
- 男性结直肠癌发病率相对风险0.76(95%CI 0.70至0.83)。
- 女性结直肠癌发病率相对风险0.83(95%CI 0.75至0.92)。
- 女性60岁以下发病率相对风险0.71(95%CI 0.59至0.84),60岁及以上0.90(95%CI 0.80至1.02)。
临床怎么用
- 可考虑将柔性乙状结肠镜作为男性及60岁以下女性的结直肠癌筛查选择。
- 对60岁以上女性,应权衡筛查获益,并考虑能更有效检测近端肿瘤的替代筛查方法。
局限性
- 研究为汇总分析,各试验筛查次数和年龄范围不完全一致。
- 筛查依从率在各项试验间存在差异(58%至87%)。
- 原文未报告长期随访中替代筛查方法的效果比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the effectiveness of flexible sigmoidoscopy in screening for colorectal cancer by patient sex and age. DESIGN: Pooled analysis of randomised trials (the US Prostate, Lung, Colorectal and Ovarian cancer screening trial (PLCO), the Italian Screening for Colon and Rectum trial (SCORE), and the Norwegian Colorectal Cancer Prevention trial (NORCCAP)). DATA SOURCES: Aggregated data were pooled from each randomised trial on incidence of colorectal cancer and mortality stratified by sex, age at screening, and colon subsite (distal v proximal). ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Invited individuals aged 55-74 (PLCO), 55-64 (SCORE), and 50-64 (NORCCAP). Individuals were randomised to receive flexible sigmoidoscopy screening once only (SCORE and NORCCAP) or twice (PLCO), or receive usual care (no intervention). RESULTS: 287 928 individuals were included in the pooled analysis; 115 139 randomised to screening and 172 789 to usual care. Compliance rates were 58%, 63%, and 87% in SCORE, NORCCAP, and PLCO, respectively. Median follow-up was 10.5 to 12.1 years. Screening reduced the incidence of colorectal cancer in men (relative risk 0.76; 95% confidence interval 0.70 to 0.83) and women (0.83; 0.75 to 0.92). No difference in the effect of screening was seen between men younger than 60 and those older than 60. Screening reduced the incidence of colorectal cancer in women younger than 60 (relative risk 0.71; 95% confidence interval 0.59 to 0.84), but not significantly in those aged 60 or older (0.90; 0.80 to 1.02). Colorectal cancer mortality was significantly reduced in both younger and older men, and in women younger than 60. Screening reduced colorectal cancer incidence to a similar extent in the distal colon in men and women, but there was no effect of screening in the proximal colon in older women with a significant interaction between sex and age group (P=0.04). CONCLUSION: Flexible sigmoidoscopy is an effective tool for colorectal cancer screening in men and younger women. The benefit is smaller and not statistically significant for women aged over 60; alternative screening methods that more effectively detect proximal tumours should be considered for these women.
引用
- Holme Ø, Schoen RE, Senore C, et al. Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials. BMJ. 2017. PMID: 28087510. doi:10.1136/bmj.i6673
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。